CHGX — Chitogenx Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Chitogenx Announces Executive Leadership Changes
Brief: Chitogenx Inc - Study Results To Be Available Q3-24 After Mandatory Post-Surgery Monitoring
Brief: Chitogenx Concludes Enrolment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Brief: Chitogenx Announces New $2.5 Million Non-Brokered Private Placement Offering And Balance Sheet Restructuring
Brief: Chitogenx Reports Its Third Quarter 2023 Results
Brief: Chitogenx Launches Second Orthopedic Development Program In Meniscus Repair
Brief: Ortho Regenerative Technologies Closes Non-Brokered $1.05 Mln Private Placement
Brief: Ortho Regenerative Technologies Announces Filing Of Response To Type A Meeting With FDA And Non-Brokered $1.5 Mln Private Placement
Brief: Ortho Regenerative Technologies Announces Successful Type A Meeting With U.S. FDA On CMC Elements
Brief: Ortho Regenerative Technologies Announces Extension Of FDA Clinical Hold Of Ortho-R Investigational New Drug Application
Brief: Ortho Regenerative Technologies Receives Clinical Hold Letter From The U.S. FDA
Brief: Ortho Regenerative Technologies Adds Patrick O'donnell To Board
Brief: Ortho Regenerative Announces Non-Brokered Private Placement Of Units
Brief: Barda And Ortho Collaborate To Advance Development Of High Specificity SARS-CoV-2 Antibody Tests
Brief: Ortho Regenerative Technologies Announces $1.1 Million Private Placement
Brief: Ortho Regenerative Technologies Inc - Safety Profile Of Ortho-R Confirmed
Brief: Ortho Regenerative Technologies Selects Us Based Specialized CRO, MCRA LLC, For Its Upcoming Phase I/II Rotator Cuff Human Trial
Brief: Ortho RTI Posts Issuance Of 3.61 Mln Shares Pursuant To Its Non-Brokered Private Placement
Brief: Ortho Rti Announces Non-Brokered Private Placement